Home » Novartis Drug Jakavi Seen as Blockbuster After Positive Data
Novartis Drug Jakavi Seen as Blockbuster After Positive Data
Novartis drug Jakavi achieved its main goal in a late-stage trial for patients suffering from a rare blood cancer, putting it on track to become a potential blockbuster treatment.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May